caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1730260027

Melissa Schreckengost

PRACTICEDUNCAN FAMILY PHYSICIANSSee all providers at this practice →
Nurse PractitionerDuncan, OKI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Melissa Schreckengost's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Nathan Elfrink
Diagnostic Radiology · Oklahoma City, OK
2394
Preston Waters
Family Practice · Duncan, OK
2197
John Alexander
Diagnostic Radiology · San Angelo, TX
1950
Demetra Cox
Family Practice · Duncan, OK
1337
HUGHES, DENNIS1239
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,074
Beneficiaries
—
Total drug cost
$83K
Distinct drugs
61
Brand share
15.9%
Top prescribed drugs
Amlodipine Besylate137 claims
Levothyroxine Sodium134 claims
Atorvastatin Calcium128 claims
Losartan Potassium104 claims
Lisinopril101 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.